Abstract

To conduct a meta-analysis and to explore the therapeutic effect of Kuntai capsules on patients with polycystic ovary syndrome. The search for relevant studies involved utilizing the Kuntai Jiaonang and Duonang Luanchao Zonghezheng terms in the China National Knowledge Infrastructure and Wanfang databases, and the Kuntai Capsule and polycystic ovary syndrome terms in the Embase, Web of science, PubMed and Cochrane library databases. Utilizing Cochrane scores, two evaluators assessed the quality of the article. The included research articles were analyzed to gather relevant data, and the effectiveness of Kuntai capsules was assessed through a meta-analysis using RevMan 5.4. Following the literature search, selection process and quality evaluation, 16 publications met the criteria for inclusion in the meta-analysis. The meta-analysis findings indicated a notable elevation in the pregnancy rate, ovulation rate and total effective rate among polycystic ovary syndrome patients treated with Kuntai capsules, as opposed to the control group. In relation to luteinizing hormone, estradiol, follicle-stimulating hormone, and T levels, the patients in the observation group exhibited substantially decreased values than those observed in the control group. Indicated by this systematic review and meta-analysis, Kuntai capsules have been found to possess substantial advantages in treating polycystic ovary syndrome patients, establishing their potential as a viable treatment option that can be promoted.